Large Cap Archives - Page 346 of 437

1 minute read

Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal

March 24, 9:18 AM

Activist Carl Icahn reportedly accused Illumina Inc (NASDAQ:ILMN) directors of demanding extra personal liability insurance before agreeing to close the $8 billion…

ILMN

2 minute read

Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic Players

By Vandana Singh

March 24, 9:06 AM

The Indian Patent Office rejected Johnson and Johnson’s (NYSE:JNJ) application to extend its patent on tuberculosis treatment, bedaquiline, beyond July 2023.…

JNJ

2 minute read

Marco Rubio Voices National Security Concerns, Calls For TikTok Ban

By AJ Fabino

March 23, 1:51 PM

Florida Sen. Marco Rubio is calling for the immediate ban of TikTok, citing it as a national security risk for America.

GOOG

2 minute read

Lawmakers Accuse TikTok Of Being National Security Threat, Call For Ban

By AJ Fabino

March 23, 1:07 PM

TikTok CEO Shou Chew is under intense scrutiny from lawmakers who believe the Chinese-owned short video app should be banned for being a potential national security threat to the U.S.

GOOG

5 minute read

Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today’s Top Stories

By Vandana Singh

March 23, 9:23 AM

Bloomberg

AAPL

1 minute read

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval

By Vandana Singh

March 23, 7:39 AM

The FDA granted accelerated approval to Incyte Corporation’s (NASDAQ:INCY) Zynyz (retifanlimab-dlwr) for adult patients with metastatic or recurrent locally advanced Merkel cell…

INCY

1 minute read

Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today

By Vandana Singh

March 23, 7:20 AM

Sanofi-Regeneron stocks are trading higher today after their blockbuster drug aced the pivotal COPD trial.

REGN

1 minute read

Concerns Over Nike’s Inventory Glut: How Will Q3 Earnings Be Affected?

By AJ Fabino

March 20, 12:44 PM

Athletic powerhouse Nike Inc (NYSE: NKE) reports third-quarter earnings Tuesday after market close; here’s what investors need to know.

NKE

1 minute read

New Four Year Data For Roche’s Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients

By Vandana Singh

March 20, 11:16 AM

Roche Holdings AG (OTC:RHHBY) announced new long-term data for Evrysdi (risdiplam) in a broad range of people aged 2-25 years with…

RHHBF

1 minute read

Analyst Writes Incyte’s Opzelura Provides Deepening, Relapse Prevention; Povo Data Intriguing In Depigmented Skin Disorder

By Vandana Singh

March 20, 10:40 AM

Incyte Corporation (NASDAQ:INCY) announced new data from a Phase 2b trial of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult…

INCY